T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
作者信息
Naranbhai Vivek, Nathan Anusha, Kaseke Clarety, Berrios Cristhian, Khatri Ashok, Choi Shawn, Getz Matthew A, Tano-Menka Rhoda, Ofoman Onosereme, Gayton Alton, Senjobe Fernando, Zhao Zezhou, St Denis Kerri J, Lam Evan C, Carrington Mary, Garcia-Beltran Wilfredo F, Balazs Alejandro B, Walker Bruce D, Iafrate A John, Gaiha Gaurav D
出版信息
Cell. 2022 Mar 31;185(7):1259. doi: 10.1016/j.cell.2022.03.022.
Abstract
摘要
相似文献
1
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.大多数但并非所有个体对新冠病毒奥密克戎变异株仍保持T细胞反应性。
Cell. 2022 Mar 31;185(7):1259. doi: 10.1016/j.cell.2022.03.022.
2
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals.在大多数但并非所有先前感染过新冠病毒和接种过疫苗的个体中，T细胞对新冠病毒奥密克戎变种的反应性得以保留。
medRxiv. 2022 Jan 5:2022.01.04.21268586. doi: 10.1101/2022.01.04.21268586.
3
Assessment of T-cell Reactivity to the SARS-CoV-2 Omicron Variant by Immunized Individuals.免疫个体对 SARS-CoV-2 奥密克戎变异株的 T 细胞反应性评估。
JAMA Netw Open. 2022 Apr 1;5(4):e2210871. doi: 10.1001/jamanetworkopen.2022.10871.
4
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.在 COVID-19 康复个体中鉴定的与 SARS-CoV-2 的奥密克戎变异株相关的突变和 CD8 T 细胞表位之间最小交叉。
mBio. 2022 Apr 26;13(2):e0361721. doi: 10.1128/mbio.03617-21. Epub 2022 Mar 1.
5
Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.奥密克戎 BA.1 突变使 SARS-CoV-2 刺突蛋白减少，导致接种疫苗和康复个体的 T 细胞反应降低。
Viruses. 2022 Jul 19;14(7):1570. doi: 10.3390/v14071570.
6
Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.肽疫苗诱导的抗体增强对 SARS-CoV-2 奥密克戎变异株的交叉识别。
Front Immunol. 2023 Jan 24;13:1044025. doi: 10.3389/fimmu.2022.1044025. eCollection 2022.
7
BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality.BNT162b2 诱导的记忆 T 细胞对奥密克戎变异株的反应具有保存的多功能性。
Nat Microbiol. 2022 Jun;7(6):909-917. doi: 10.1038/s41564-022-01123-x. Epub 2022 May 16.
8
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S.奥密克戎变异株感染对使用EUROIMMUN Quan-T-Cell SARS-CoV-2检测法和罗氏Elecsys抗SARS-CoV-2-S检测法评估刺突蛋白特异性免疫反应的影响
Diagnostics (Basel). 2023 Mar 8;13(6):1024. doi: 10.3390/diagnostics13061024.
9
Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals.接种卫星五号疫苗的个体对新冠病毒奥密克戎变种的中和反应持久性
Vaccines (Basel). 2022 May 21;10(5):817. doi: 10.3390/vaccines10050817.
10
Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.非重症奥密克戎变异株 SARS-CoV-2 感染患者的免疫与病毒脱落持续时间的关系。
Front Public Health. 2022 Dec 22;10:1032957. doi: 10.3389/fpubh.2022.1032957. eCollection 2022.
引用本文的文献
1
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19.一种用于COVID-19的奥密克戎特异性、自我扩增单价mRNA疫苗加强针的细胞免疫广度。
NPJ Vaccines. 2025 Mar 1;10(1):42. doi: 10.1038/s41541-025-01076-2.
2
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection.一种二价新冠病毒mRNA疫苗引发了广泛的免疫反应并提供了针对奥密克戎亚变体感染的保护。
NPJ Vaccines. 2025 Jan 10;10(1):4. doi: 10.1038/s41541-025-01062-8.
3
A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2.一种基于多抗原性口疮病毒的疫苗能有效保护仓鼠和非人灵长类动物免受严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染。
NPJ Vaccines. 2024 Oct 16;9(1):191. doi: 10.1038/s41541-024-00981-2.
4
SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants.SARS-CoV-2 特异性 T 细胞作为一种针对新兴 COVID-19 变异株免疫逃逸的有效治疗策略。
Int J Mol Sci. 2024 Sep 29;25(19):10512. doi: 10.3390/ijms251910512.
5
SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants.SARS-CoV-2 之旅：从阿尔法变异株到奥密克戎及其亚变异株。
Infection. 2024 Jun;52(3):767-786. doi: 10.1007/s15010-024-02223-y. Epub 2024 Mar 30.
6
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer.mRNA 疫苗针对 SARS-CoV-2 可诱导肺癌患者产生不同的抗原特异性 T 细胞反应。
J Immunother Cancer. 2024 Jan 4;12(1):e007922. doi: 10.1136/jitc-2023-007922.
7
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant.SARS-CoV-2 BA.2.86 亚变种的进化和中和逃逸。
Nat Commun. 2023 Dec 6;14(1):8078. doi: 10.1038/s41467-023-43703-3.
8
Differential peripheral blood mononuclear cell reactivity against SARS-CoV-2 proteins in naïve and previously infected subjects following COVID-19 vaccination.新冠病毒疫苗接种后，初免和既往感染过新冠病毒的受试者外周血单个核细胞对SARS-CoV-2蛋白的反应差异。
Clin Immunol Commun. 2022 Dec;2:172-176. doi: 10.1016/j.clicom.2022.11.004. Epub 2022 Dec 1.
9
SARS-CoV-2 infection establishes a stable and age-independent CD8 T cell response against a dominant nucleocapsid epitope using restricted T cell receptors.SARS-CoV-2 感染利用受限的 T 细胞受体建立了针对主要核衣壳表位的稳定且与年龄无关的 CD8 T 细胞应答。
Nat Commun. 2023 Oct 23;14(1):6725. doi: 10.1038/s41467-023-42430-z.
10
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELD and COVAXIN induced immunity in COVID-19 exposed Indians.与中和抗体相关的多功能CD4 T细胞是COVISHIELD和COVAXIN在接触过新冠病毒的印度人身上诱导免疫的一个标志。
NPJ Vaccines. 2023 Sep 14;8(1):134. doi: 10.1038/s41541-023-00731-w.
Zotero 插件